Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 17 | 78214076 | upstream gene variant | C/G;T | snv |
|
Neoplasms | 0.030 | 0.667 | 3 | 2019 | 2020 | ||||||||
|
0.925 | 0.080 | 17 | 78214076 | upstream gene variant | C/G;T | snv |
|
Neoplasms | 0.030 | 0.667 | 3 | 2019 | 2020 | ||||||||
|
0.851 | 0.160 | 17 | 78224125 | 3 prime UTR variant | T/C | snv | 0.40 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.851 | 0.160 | 17 | 78224125 | 3 prime UTR variant | T/C | snv | 0.40 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 17 | 78224125 | 3 prime UTR variant | T/C | snv | 0.40 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.160 | 17 | 78224125 | 3 prime UTR variant | T/C | snv | 0.40 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.160 | 17 | 78224125 | 3 prime UTR variant | T/C | snv | 0.40 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 17 | 78214076 | upstream gene variant | C/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.080 | 17 | 78214076 | upstream gene variant | C/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 17 | 78214076 | upstream gene variant | C/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.080 | 17 | 78214076 | upstream gene variant | C/G;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.080 | 17 | 78224418 | 3 prime UTR variant | G/A | snv | 5.0E-04 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 17 | 78212770 | upstream gene variant | C/G;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 0.080 | 17 | 78214998 | 3 prime UTR variant | T/C | snv | 0.11 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.807 | 0.200 | 17 | 78213692 | upstream gene variant | G/C | snv | 0.33 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | < 0.001 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 17 | 78213673 | upstream gene variant | T/C | snv | 0.41 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.695 | 0.280 | 17 | 78214286 | 5 prime UTR variant | G/A;C;T | snv | 0.38; 4.8E-06 |
|
Neoplasms | 0.080 | 1.000 | 8 | 2012 | 2020 | |||||||
|
0.695 | 0.280 | 17 | 78214286 | 5 prime UTR variant | G/A;C;T | snv | 0.38; 4.8E-06 |
|
Neoplasms | 0.080 | 1.000 | 8 | 2012 | 2020 | |||||||
|
0.695 | 0.280 | 17 | 78214286 | 5 prime UTR variant | G/A;C;T | snv | 0.38; 4.8E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2018 | 2019 |